Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor site revision from v3.4.1 to v3.4.2 with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary option added; capitalization adjusted for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision/version updated to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedOnly a behind-the-scenes revision update was made: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content, endpoints, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added with Michigan and New York. Separate Michigan Locations and New York Locations subsections were removed, and the HHS Vulnerability Disclosure footer link was removed.SummaryDifference0.3%

- Check91 days agoChange DetectedThe only change is a site revision update (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.